Telemedicine in the Management of Inflammatory Bowel Disease: An Updat | SHTT – Dove Medical Press

Posted: Published on March 5th, 2020

This post was added by Alex Diaz-Granados

Sumona Bhattacharya,1 Uni Wong,2 Raymond K Cross2

1Digestive Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 2University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD, USA

Correspondence: Raymond K Cross University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, 685 West Baltimore Street, Suite 8-00, Baltimore, MD 21201, USA Tel +1 410-706-3387 Fax +1 410-706-4330 Email rcross@som.umaryland.edu

Abstract: Crohns disease and ulcerative colitis are the two most common subtypes of inflammatory bowel disease. Most studies show that this patient population is increasing in incidence. Patients with these diseases require lifelong care by experienced practitioners however the traditional medical model is not ideal for patients who require continuous close monitoring and whose symptoms may dramatically worsen between regularly scheduled visits. Patients with uncontrolled disease may experience abdominal pain, diarrhea, and rectal bleeding and such patients are at increased risk for complications that may necessitate hospitalization and emergency surgery. Traditional medical care can be supplemented by telemedicine, which is the delivery of health care through remote electronic communication, for example, through web-based computer or smartphone applications. Here we describe several studies that highlight the many ways in which telemedicine can augment and improve patient care through telemonitoring, telemanagement, televisit, and teleconsultation.

Keywords: inflammatory bowel disease, crohns disease, ulcerative colitis, telemedicine, telehealth, telemonitoring, telemanagement, televisit, teleconsultation

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the rest here:
Telemedicine in the Management of Inflammatory Bowel Disease: An Updat | SHTT - Dove Medical Press

Related Posts
This entry was posted in Ulcerative Colitis. Bookmark the permalink.

Comments are closed.